...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Vaccine >Cost-benefit analysis of routine childhood vaccination against chickenpox in Taiwan: decision from different perspectives
【24h】

Cost-benefit analysis of routine childhood vaccination against chickenpox in Taiwan: decision from different perspectives

机译：台湾儿童常规接种水痘的成本效益分析：不同角度的决策

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Cost-benefit analysis was conducted to determine whether it is worthwhile to initiate a routine varicella vaccination program in Taiwan from different perspectives. Using the human capital approach, the discounted net cost for vaccination program was New Taiwan Dollars (NTD) 281 million from health care payer's perspective. Taking indirect costs into account, the net saving due to vaccination program was NTD 425 million from the societal perspective. In terms of benefit-cost ratio, a mass varicella vaccination program could only save NTD 0.34 in discounted costs for each dollar incurred in a vaccination program from health care payer's perspective whereas save NTD 2.06 from the societal viewpoint. Results based on the willingness-to-pay (WTP) method showed the Net Present Value (NPV) of the vaccination program was estimated as -NTD 272 million.
机译：进行了成本效益分析，以确定从不同角度在台湾启动例行水痘疫苗接种计划是否值得。使用人力资本方法，从医疗保健支付者的角度来看，疫苗接种计划的折现净成本为新台币2.81亿元。考虑到间接成本，从社会角度看，疫苗接种计划净节省的费用为新台币4.25亿元。就利益成本比而言，从医疗保健支付者的角度来看，大规模水痘疫苗接种计划仅能为疫苗接种计划每产生1美元的折扣成本，可节省NTD 0.34，而从社会角度而言，节省的NTD 2.06。根据付款意愿（WTP）方法的结果显示，疫苗接种计划的净现值（NPV）估计为-2.72亿新台币。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号